EPIX — ESSA Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for ESSA Pharma, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	78.3	195	167	148	127
Net Total Accounts Receivable
Net Total Receivables	0.31	0.489	0.006	0.135	0.163
Prepaid Expenses
Total Other Current Assets
Total Current Assets	80.3	198	169	149	128
Net Property, Plant And Equipment	—	0.308	0.186	0.068	0.295
Other Long Term Assets
Total Assets	80.6	198	170	149	128
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.2	3.93	2.31	3.5	3.3
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1.33	4.16	2.39	3.5	3.51
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	79.2	194	167	146	125
Total Liabilities & Shareholders' Equity	80.6	198	170	149	128
Total Common Shares Outstanding